AngioDynamics to Acquire RadiaDyne to Expand Oncology Portfolio
AngioDynamics Inc. announced an agreement to acquire RadiaDyne, a privately held medical diagnostic and device company that designs and develops patient dose monitoring technology to improve cancer treatment outcomes.